Biotech
-
546AVEO Pharmaceuticals Inc (NASDAQ:AVEO) Surging On Narrowing Net Loss And Positive Clinical Trials
AVEO Pharmaceuticals Inc (NASDAQ: AVEO) has what it takes to continue moving higher after rallying by more than 90% over the past...
-
275Imagin Medical Inc (CNSX: IME) Looks To Have Bottomed Out
Imagin Medical Inc (CNSX: IME) underperformance over the past year is a point of concern. The stock has shed more than 60%...
-
556Emerald Bioscience Inc (OTCMKTS: EMBI) Spikes To Two-Year Highs
Emerald Bioscience Inc (OTCMKTS: EMBI) restructuring has paid off if a spike in share price and market activity in recent months is...
-
520Theratechnologies Inc (OTCMKTS: THERF) Undervalued With Tremendous Potential
Theratechnologies Inc (OTCMKTS: THERF) finds itself in a tight spot engulfed in a tight trading range. The stock has struggled to power...
-
560Vilacto Bio Inc (OTCMKTS: VIBI) Upside Gains Likely On LACTOACTIVE Patent Boost
Vilacto Bio Inc (OTCMKTS: VIBI) market activity and share price are trending higher, as the company inches closer to securing an essential...
-
591Arrayit Corp (OTCMKTS: ARYC) Allergy Testing Services Gain Traction
Shares of Arrayit Corp (OTCMKTS: ARYC) have taken a flight ever since the company increased its weekly guidance for medical billing associated...
-
565Elite Pharmaceuticals Inc (OTCMKTS: ELTP): Bulls Must Defend To Avert Further Slides
Shares of Elite Pharmaceuticals Inc (OTCMKTS: ELTP) appear to have hit a critical resistance level if a recent pullback is anything to...
-
784What’s Next For Neurotrope Inc (NASDAQ: NTRP)?
Neurotrope Inc (NASDAQ: NTRP) is a biotech that we covered a lot back in 2017 when the stock was trading like a rocket...
-
1.2KWill Biogen Inc (NASDAQ: BIIB) Buy Anavex Life Sciences Corp (NASDAQ: AVXL)?
After the news broke last week that Biogen Inc (NASDAQ: BIIB) and development partner Eisai (OTCMKTS: ESALY) decided to terminate two late-stage studies,...
-
545Sorrento Therapeutics Inc (NASDAQ: SRNE) On The Move
Sorrento Therapeutics Inc (NASDAQ: SRNE) is a name that we last covered back in 2017. We talked about the stock when it...
